About | Free Trial

Last Update

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Neil Berinstein?

Dr. Neil Berinstein L. MD

Chief Scientific Officer

IRX Therapeutics Inc

Direct Phone: (631) ***-****       

Email: n***@***.com

IRX Therapeutics Inc

140 West 57Th St. Suite 9C

New York, New York 10019

United States

Company Description

IRX Therapeutics develops immune therapies to treat cancer and related diseases. The company's therapies are designed to target and restore the immune system in order to improve a patient's response to next-generation cancer vaccines and novel targeted th... more

Find other employees at this company (27)

Background Information

Employment History

Director of Translational Research
Ontario Institute for Cancer Research

Affiliations

Science Advisory Board
ImmunoVaccine Technologies Inc.

Part of the Executive Steering Committee
Aventis SA

Scientific Advisory Board Member
Molecular Templates Inc

Advisory Boards Member
Phacilitate Limited

Board Member
Canadian Blood and Marrow Transplant Group

Member
Leukemia Research Fund

Post-Doctoral Fellow
Stanford University

Education


Internal Medicine and Medical Oncology
University of Toronto

M.D.
Department of Medicine

MD

University of Manitoba

Medical Doctoral Degree

University of Manitoba

pre-medical degree

University of Manitoba

Web References (173 Total References)


Dr. Neil Berinstein, ...

oicr.on.ca [cached]

Dr. Neil Berinstein, Director of Translational Research at OICR and an expert in the strategic and operational development of cancer vaccines, will provide critical expertise to BioCanR x. The Canadian Cancer Clinical Trials Network (3CTN), an organization based at OICR, will provide the clinical trial expertise critical to the development of new anti-cancer bio-therapeutic products.


The Essential Cancer Treatment Nutrition Guide and Cookbook ยป

www.jeanlamantia.com [cached]

Dr. Neil Berinstein is a medical oncologist at the Odette Cancer Centre at Sunnybrook hospital, an associate scientist and professor in the department of Medicine at University of Toronto.


Neil Berinstein, ...

www.newevidence.com [cached]

Neil Berinstein, MD Dr. Neil Berinstein earned his pre-medical degree and Medical Doctorate from the University of Manitoba and received further specialty and research training at the University of Toronto and Stanford University. Dr. Berinstein currently holds multiple academic and professional positions, including as a Professor in the Department of Medicine at the University of Toronto, and he is on the active staff of the Hematology Oncology Site Group at the Odette Cancer Centre of the Sunnybrook Health Sciences Centre. He is currently the Director of Translational Research at the Ontario Institute for Cancer Research. Dr. Berinstein specializes in the management and research of patients with lymphoproliferative disorders, including non-Hodgkin lymphoma, chronic lymphocytic leukemia, Hodgkin lymphoma, and myeloma. Dr. Berinstein has received numerous grants throughout his career for his research, which focuses on the development of novel immunotherapeutic and targeted approaches for cancer and hematologic malignancies. He has published six book chapters and over 100 peer-reviewed, invited, or review papers.


Neil Berinstein, ...

www.newevidence.com [cached]

Neil Berinstein, MD Dr. Neil Berinstein earned his pre-medical degree and Medical Doctorate from the University of Manitoba and received further specialty and research training at the University of Toronto and Stanford University. Dr. Berinstein currently holds multiple academic and professional positions, including as a Professor in the Department of Medicine at the University of Toronto, and he is on the active staff of the Hematology Oncology Site Group at the Odette Cancer Centre of the Sunnybrook Health Sciences Centre. He is currently the Director of Translational Research at the Ontario Institute for Cancer Research. Dr. Berinstein specializes in the management and research of patients with lymphoproliferative disorders, including non-Hodgkin lymphoma, chronic lymphocytic leukemia, Hodgkin lymphoma, and myeloma. Dr. Berinstein has received numerous grants throughout his career for his research, which focuses on the development of novel immunotherapeutic and targeted approaches for cancer and hematologic malignancies. He has published six book chapters and over 100 peer-reviewed, invited, or review papers.


Neil Berinstein, ...

www.newevidence.com [cached]

Neil Berinstein, MD Dr. Neil Berinstein earned his pre-medical degree and Medical Doctorate from the University of Manitoba and received further specialty and research training at the University of Toronto and Stanford University. Dr. Berinstein currently holds multiple academic and professional positions, including as a Professor in the Department of Medicine at the University of Toronto, and he is on the active staff of the Hematology Oncology Site Group at the Odette Cancer Centre of the Sunnybrook Health Sciences Centre. He is currently the Director of Translational Research at the Ontario Institute for Cancer Research. Dr. Berinstein specializes in the management and research of patients with lymphoproliferative disorders, including non-Hodgkin lymphoma, chronic lymphocytic leukemia, Hodgkin lymphoma, and myeloma. Dr. Berinstein has received numerous grants throughout his career for his research, which focuses on the development of novel immunotherapeutic and targeted approaches for cancer and hematologic malignancies. He has published six book chapters and over 100 peer-reviewed, invited, or review papers.

Similar Profiles

Other People with this Name

Other people with the name Berinstein

Florencia Berinstein
//www.wahc-museum.ca/

Henry Berinstein
Aegis Capital Corp.

Juana Berinstein
Association of Ontario Midwives

Corinne Berinstein
University of Toronto

Jan Berinstein
Legal IT Professionals Web Site

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory